Comparative potencies and beta2‐adrenoreceptor selectivities of rimiterol and salbutamol aerosols.
Open Access
- 1 February 1977
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 4 (1) , 77-79
- https://doi.org/10.1111/j.1365-2125.1977.tb00671.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.1975
- Intravenous treatment with rimiterol and salbutamol in asthma.BMJ, 1975
- Comparison of the beta2‐adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.British Journal of Clinical Pharmacology, 1975
- Comparison Between the Bronchodilator and Cardiovascular Effects of Inhaling 0.5 mg. Riraiterol (‘Pulmadil’) and 0.2 mg. SalbutamolCurrent Medical Research and Opinion, 1975
- Response to Rimiterol and Salbutamol Aerosols Administered by Intermittent Positive-pressure VentilationBMJ, 1974
- The Pharmacokinetics of Rimiterol in ManXenobiotica, 1974
- Clinical assessment of bronchodilator drugs delivered by aerosolThorax, 1973
- The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.1972
- Preliminary Studies of a New Bronchodilator (WG 253) in ManThe Journal of Clinical Pharmacology and New Drugs, 1971
- Comparison of Cardiorespiratory Effects of Isoprenaline and Salbutamol in Patients with Bronchial AsthmaBMJ, 1970